Skip to main content

MDP · Medexus Pharmaceuticals Inc. · Financials

5.1200 CAD +0.2000 (+4.07%) At close · Nov 6 Intraday price with Plus
Market Cap
160.90M CAD
Shares
31.43M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
$99.33M -8.3%
FY2026 Revenue FY2025–FY2026
Net Income
-$2.39M -206.5%
FY2026 Net Income FY2025–FY2026
Gross Margin
54.78% +2.6pp
FY2026 Gross Margin FY2025–FY2026
Operating Margin
5.17% -2.4pp
FY2026 Operating Margin FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025
$99.33M $108.33M
$54.41M $56.58M
54.78% 52.23%
$5.14M $8.22M
5.17% 7.59%
-$2.27M $1.44M
-$2.39M $2.25M
-2.41% 2.07%
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.